Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT03710460
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed grade 1 obesity according to the WHO criteria:
* -Body Mass Index (BMI) between 30 to 34.9 kg/m²
* No pharmacological treatment for obesity
* Stable weight during the last 3 months
Exclusion Criteria:
* Pregnancy or breast-feeding
* History of kidney or liver disease
* Drugs or supplements consumption with proven properties that modify the behavior of obesity
* Total cholesterol \>240 mg/dL
* Triglycerides \>500mg/dL
* Glucose ≥126 mg/dL or HbA1C ≥6.5%.
* Patients who smoke daily for the last 6 months
* Hypersensitivity to dapagliflozin or metformin XR
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
31 Years
Maximum Age:
60 Years
Study:
NCT03710460
Study Brief:
Protocol Section:
NCT03710460